| 【Company Research】Xiaomi (1810 HK) – 3Q21E preview: improving margin to offset muted smartphone growth |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – Q3 slightly miss while long-term growth prospects remain intact |
| 【Company Research】Alibaba (BABA US) – FY22E rev guiding down to 20%-23% YoY |
| 【Company Research】PA Good Doctor (1833 HK) – Adopting new strategy for high quality growth |
| 【Company Research】Baidu (BIDU US) – Ads headwinds to linger in 4Q21E & 1Q22E |
| 【Company Research】ZTO Express (ZTO US) – Upbeat guidance on profitable growth in 2022E; raising earnings forecast and TP |
| 【Company Research】ZTO Express (2057 HK) – Upbeat guidance on profitable growth in 2022E; raising earnings forecast and TP |
| 【Fixed Income Research】HRINTH – Capital injection realizes, Neutral post rally |
| 【Fixed Income Research】AGILE – EBs issue strengthened liquidity |
| 【Company Research】Bilibili (BILI US) – Mixed 3Q21, with stepping-up content investment |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
